Bright light therapy for fatigue and depression in prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This Phase 2 study tests whether a “bright white light” intervention can reduce cancer-related fatigue and depression in people with advanced prostate cancer receiving hormone-based treatment. If it works, it could improve day-to-day well-being while you’re on standard cancer therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have prostate cancer confirmed by pathology (biopsy or other test)
- Have measurable or metastatic prostate cancer visible on CT/MRI or a bone scan/PET scan
- Be 60 years or older and able to do usual activities fairly well (ECOG 0–2)
- Be able to start and continue the planned hormone treatment plan (ADT plus certain add-on medicines like docetaxel/abiraterone/prednisone or ADT plus enzalutamide/apalutamide/darolutamide)
- Have blood test results within required ranges (enough white blood cells, neutrophils, and platelets) and adequate liver/kidney function
- Be willing to take part and sign informed consent; also be medically able to safely receive bright light (no seizure history, not light-sensitive, and no major untreated eye problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether light therapy and an occupational therapy fatigue program can reduce fatigue in people with certain urinary-system cancers who still have mild fatigue during treatment. It may help you feel more energized and manage day-to-day activity while cancer treatment is ongoing.
This trial tests proton radiation therapy for people with high-risk prostate cancer. It may help by delivering radiation in a more targeted way, with the goal of controlling the cancer while reducing exposure to nearby healthy tissue.
This trial tests a special bright light therapy designed to help your body's natural sleep-wake cycle. It is being studied for people with advanced melanoma who are about to receive TIL therapy, a treatment that uses your own immune cells to fight the cancer. The light therapy might help improve how you feel during treatment.
This trial tests a light-based treatment called photobiomodulation to see if it can help with memory and thinking problems that some people have after cancer treatment. It is for people who finished chemotherapy or radiation more than 6 months ago but less than 5 years ago, and who notice cognitive issues.
This trial tests whether giving a short course of hormone therapy (apalutamide) along with targeted, high-dose radiation (SBRT) is safe and effective for men with a specific type of intermediate-risk prostate cancer. You may benefit if you fit the exact risk and test criteria.
This trial tests whether bright light therapy can help reduce tiredness in people who have finished cancer treatment. It may improve energy and quality of life for cancer survivors.
Hear when a new Advanced Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.